This Government Contract opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Pharmaceutical Supply – Isoniazid Tablets (300 mg)

Closed

Federal

Submission Closed07/22/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of FDA-Regulated Medical Dye Solution (Plastic L)The Department of Defense, through the Medical Supply Chain MD Surg FSF, is seeking a subcontractor for the manufacture and delivery of three pints of FDA-regulated Plastic L dye solution. The supplier must ensure the product is compliant with current Good Manufacturing Practices, specific shelf-life requirements, and federal medical packaging standards. This subcontract opportunity falls under NAICS code 325412 and is designated for performance at APO 09227. Interested parties must submit their responses by September 8, 2026, following the posting date of August 31, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Abbott BinaxNOW COVID-19 Antigen Test KitsThis subcontract opportunity with the Department of Defense, specifically the Medical Supply Chain MD Surg FSF, involves the supply of Abbott BinaxNOW COVID-19 Antigen test kits. These kits are intended for at-home, over-the-counter use and must strictly adhere to FDA regulations, as well as specific packaging, labeling, and domestic content requirements. The procurement is categorized under NAICS code 325412. The response deadline for this requirement is September 8, 2026, with the place of performance located at FPO 96675-9600.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Pharmaceutical Manufacturer for Citalopram Hydrobromide TabletsThis subcontract involves the manufacture and supply of Citalopram Hydrobromide Tablets for the Department of Defense, specifically under the Medical Supply Chain Pharm FSA. The contractor must ensure all products are compliant with FDA and USP regulations, as well as military packaging standards per MIL-STD-2073-1E, for National Stock Number 6505015054632. The performance of this contract is located at Fort Stewart, Georgia. Interested parties must submit their responses by September 8, 2026, following the posting date of August 31, 2026. The project falls under NAICS code 325412 for pharmaceutical manufacturing.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Topical Analgesic Gel Manufacturing and SupplyThis subcontract involves the full-scale manufacturing, quality control, packaging, and supply of topical analgesic gel, identified by NSN 6505-01-658-7643. The project requires strict compliance with military and hazardous materials regulations to ensure the product meets all necessary safety and performance standards. The contract is issued by the Department of Defense through the Medical Supply Chain Pharm FSA, with the place of performance located at Fort Riley, ZIP code 66442-0000. Under NAICS code 325412, the solicitation was posted on August 31, 2026, with a response deadline of September 3, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Domestic Sourcing of Raw Materials and ComponentsThis subcontract, titled Domestic Sourcing of Raw Materials and Components, is issued by the Department of Defense under the Medical Supply Chain MD Surg FSF. The contract focuses on the procurement of U.S.-sourced raw materials, specifically sterile gauze, burn ointments, gloves, and packaging films. All supplied materials must strictly comply with the Buy American and Berry Amendment requirements to ensure domestic sourcing. The place of performance for this contract is located at Fort Bliss, Texas. Interested parties must submit their responses by the deadline of September 8, 2026. The procurement falls under NAICS code 325412 and is managed through the DLA DIBBS system.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Pharmaceutical Manufacturing – Albendazole Tablets, USPThis subcontract through the Department of Defense Medical Supply Chain Pharma FSA involves the manufacture of prescription-grade Albendazole tablets. The selected provider must ensure all products meet USP standards, with responsibilities encompassing formulation, compression, quality control, and the provision of detailed batch documentation. The project is categorized under NAICS code 325412 and will be performed at Fort Bragg, zip code 28310. Interested parties must submit their responses by September 8, 2026, following the posting date of August 31, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

INSECT REPELLENT SPRAY

Solicitation # SPE2DP-26-T-4797

This contract is a solicitation from the Department of Defense Medical Supply Chain Pharmacy FSA for the procurement of 35 units of a non-DEET insect repellent spray. The required product must be 100 percent biodegradable, feature a citrus scent, and be provided in 2 ounce containers. Delivery is required within 20 days after the order is placed, with the place of performance located at APO 96338-5011. Compliance with specific technical and quality standards is mandatory, including DLA packaging requirements and Medical Marking Standard No. 1. Because the item is classified as hazardous material, the supplier must provide a current Material Safety Data Sheet to the DLA electronic mailbox and include a physical copy of the MSDS with every shipment. All packaging must adhere to 49 CFR and ICAO technical regulations.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4808

This contract is for the procurement of Enrofloxacin tablets, a broad-spectrum antibacterial medication for veterinary use in dogs and cats. The tablets have a 7 percent concentration of 68 mg and are supplied in bottles containing 250 tablets each. The item must be stored at controlled room temperature and adheres to a non-extendable shelf life of 36 months. The order consists of one bottle under contract SPE2DP-26-T-4808, with delivery required within five days. The product is regulated by the FDA and must comply with DLA packaging requirements and Medical Marking Standard No. 1. Delivery is set as FOB destination, with inspection and acceptance occurring at the destination point.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM CHLORIDE INJECT

Solicitation # SPE2DP-26-T-4816

This contract is for the procurement of Sodium Chloride 0.9% Injection, USP 500 ML, with a unit of issue consisting of 24 units per package. The item is regulated by the FDA and must adhere to Medical Marking Standard No. 1 and DLA packaging requirements. A critical shelf-life requirement of 24 months applies, and the product must be delivered in suitable sealed unit containers within a commercial exterior shipping container. The agreement specifies that mercury or mercury-containing compounds shall not be intentionally added to the supplies. Delivery is set as FOB Destination with an inspection and acceptance point also at the destination, requiring delivery within 20 days. The procurement is managed by the Department of Defense Medical Supply Chain Pharma FSA for performance at Fort Bliss, Texas.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

FERRIC SUBSULFATE SOLU

Solicitation # SPE2DP-26-T-4812

This contract is for the procurement of Ferric Subsulfate Solution, Monsels, supplied in packages of 12 bottles, each containing 8 ml. The solution is intended for direct application to surgical sites following the excision of diseased tissue. Strict storage prohibitions apply, as the material must not be stored in aluminum, carbon steel, copper, copper alloys, zinc, or nickel. The item has a non-extendable shelf life of 24 months, and no more than three months may have elapsed from the date of manufacture to the date of delivery to the government. The order consists of three packages to be delivered FOB destination to Joint Base Charleston, South Carolina, within 20 days. All materials must be marked according to Medical Marking Standard No. 1 and packaged in sealed unit containers to prevent damage. The contract specifies that shipping must be conducted via traceable means, explicitly prohibiting the use of parcel post. Compliance with DLA packaging requirements and specific technical quality standards is mandatory for the fulfillment of this acquisition.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

VECURONIUM BROMIDE FOR

Solicitation # SPE2DP-26-T-4814

This contract is for the procurement of Vecuronium Bromide for Injection, provided as a freeze-dried powder with 10mg of active ingredient per vial. The unit of issue is a package of 10 vials, and the product must be stored at 20 to 25 degrees Celsius and protected from light. The total shelf life is 24 months, with a requirement that at least 21 months of shelf life remain upon receipt by the government. The agreement specifies delivery to Fort Bragg, North Carolina, with a delivery timeframe of five days. Packaging must adhere to DLA and commercial standards, including Medical Marking Standard No. 1 and ASTM D3951, ensuring items are sealed and protected from damage. Shipping must be conducted via the fastest traceable means, excluding parcel post, and must comply with specific DLA packaging and palletization requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHARCOAL, ACTIVATED, SUS

Solicitation # SPE2DP-26-T-4794

This solicitation, issued by the DLA Troop Support Medical Supply Chain Pharm FSA under solicitation number SPE2DP-26-T-4794, is a request for quotations for Activated Charcoal Suspension (NSN 6505-01-282-8880). The procurement consists of multiple line items totaling 57 bottles, with each unit being a 240 ml bottle. The contract is a fixed-price acquisition requiring delivery within 20 days to various locations, including the USS KIDD DDG 100, Fort Bragg NC, and an FPO address. All items must be delivered FOB Destination, with inspection and acceptance occurring at the destination. The technical requirements mandate that the product be stored at a controlled room temperature between 20° to 25°C and must have a 36-month shelf life, with no more than five months having elapsed between the date of manufacture and the date of delivery. Packaging must comply with DLA requirements, specifically RP001 for palletization and ASTM D3951 for commercial packaging if the material is non-hazardous. Labels must clearly display the NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. Offerors are subject to various federal regulations, including the Buy American Act, cybersecurity safeguarding requirements, and strict prohibitions regarding human trafficking and hazardous material handling. Quotations must be submitted by the deadline of September 8, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 19 hours ago

DEADLINE

in 7 days

AI Contract Overview

The contract requires the supply of FDA-approved Isoniazid Tablets USP, 300 mg, packaged in bottles of 100 units, meeting all federal pharmaceutical and defense supply chain compliance standards. The product must adhere to stringent quality and regulatory requirements to ensure suitability for use within military and federal healthcare systems, with packaging and labeling conforming to specific governmental specifications. The solicitation is issued under the NAICS code 325412 for pharmaceutical preparation manufacturing and is classified as a subcontract within the Department of Defense’s Medical Supply Chain Pharm FSA procurement framework. Performance is designated to occur at the FPO address with ZIP code 09570, indicating delivery to a military mail facility. The request is open for responses between July 16, 2026, and July 22, 2026, with no set-aside provisions specified, meaning all qualified suppliers may compete. The procurement is administered through the DLA DIBBS platform, and while no point of contact is listed, the official solicitation details can be accessed via the provided DIBBS link. Suppliers must ensure full compliance with defense logistics standards, including traceability, documentation, and packaging integrity, to meet the operational needs of the Department of Defense’s pharmaceutical supply chain.

General Info

Supply FDA-approved 300 mg Isoniazid Tablets in 100-count bottles for DoD medical supply chain by July 22, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

FPO, AE, 09570, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-4184.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

ISONIAZID TABLETS

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedJul 16

subcontract

Response DeadlineJul 22

Deadline has passed

Submission Closed

07/22/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Supply of FDA-approved Isoniazid Tablets USP, 300 mg, packaged in bottles of 100 units, compliant with federal pharmaceutical and defense supply chain standards.